Health Care & Life Sciences » Pharmaceuticals | SCI Pharmtech Inc.

SCI Pharmtech Inc. | Income Statement

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,293
1,492
1,811
1,903
1,301
1,940
Cost of Goods Sold (COGS) incl. D&A
896
1,030
1,174
1,131
923
1,213
Gross Income
397
462
636
772
378
727
SG&A Expense
191
166
197
256
144
211
EBIT
206
295
440
516
235
516
Unusual Expense
-
-
2
1
4
-
Non Operating Income/Expense
2
52
18
11
4
27
Interest Expense
3
8
9
2
-
-
Pretax Income
206
341
451
506
235
545
Income Tax
34
70
78
89
44
98
Equity in Affiliates
12
6
-
-
-
-
Consolidated Net Income
160
265
374
417
191
447
Net Income
160
265
374
417
191
447
Net Income After Extraordinaries
160
265
374
417
191
447
Net Income Available to Common
160
265
374
417
191
447
EPS (Basic)
2.65
3.83
5.17
5.34
2.41
5.63
Basic Shares Outstanding
60
69
72
78
79
79
EPS (Diluted)
2.31
3.43
4.78
5.22
2.39
5.57
Diluted Shares Outstanding
70
79
80
80
80
80
EBITDA
329
430
570
649
361
648
Non-Operating Interest Income
1
2
1
1
1
2

About SCI Pharmtech

View Profile
Address
No. 61, Lane 209, Haihu North Road
Taoyuan 338 56
Taiwan
Employees -
Website http://www.sci-pharmtech.com.tw
Updated 07/08/2019
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. It focuses in the research, development, process, manufacture and sale of active pharmaceutical ingredient (API), API intermediates, and special and precision chemicals. The company's products are used for anti-epilepsy, anticonvulsant, sleeping pills, anesthesia, arrhythmia, antibiotics, anti-anorexia agents, smoking cessation drug, hypertension, antiparkinsonian, diet pills, anti-AIDS, steroid, and antidepressant.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.